Does Time-to-Chemotherapy after Primary Complete Macroscopic Cytoreductive Surgery Influence Prognosis for Patients with Epithelial Ovarian Cancer? A Study of the FRANCOGYN Group

Does Time-to-Chemotherapy after Primary Complete Macroscopic Cytoreductive Surgery Influence Prognosis for Patients with Epithelial Ovarian Cancer? A Study of the FRANCOGYN Group

To determine if the time-to-chemotherapy (TTC) after primary macroscopic complete cytoreductive surgery (CRS) influences recurrence-free survival (RFS) and overall survival (OS) in patients with epithelial ovarian cancer (EOC). We conducted an observational multicenter retrospective cohort analysis...

Full description

Bibliographic Details
Main Authors: Grégoire Rocher, Thomas Gaillard, Catherine Uzan, Pierre Collinet, Pierre-Adrien Bolze, Marcos Ballester, Sofiane Bendifallah, Lobna Ouldamer, Cyril Touboul, Cyrille Huchon, Vincent Lavoue, Yohann Dabi, Cherif Akladios, Charles Coutant, Emilie Raimond, Alexandre Bricou, Geoffroy Canlorbe, Henri Azaïs
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Journal of Clinical Medicine
Subjects:
epithelial ovarian cancer
chemotherapy
prognosis
Online Access:https://www.mdpi.com/2077-0383/10/5/1058

Internet

https://www.mdpi.com/2077-0383/10/5/1058

Similar Items